44 studies found for:    " January 13, 2013":" February 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 13, 2013":" February 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Steady State PK in Malnourished HIV Infected Children
Conditions: HIV Positive;   Malnourished
Intervention: Drug: ZDV+3TC+LPV/r
2 Not yet recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: HIV-positive Subjects With HIV-RNA <50 Copies/mL
Interventions: Drug: RPV + DRV/r;   Drug: subjects will continue the PI/r-containing regimen that is on-going at the time of enrollment.
3 Active, not recruiting Clinic-based ART Diagnostic Evaluation
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection;   RNA Virus Infections;   Virus Diseases
Intervention: Other: HIV-1 viral load testing
4 Active, not recruiting Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: Placebo to match E/C/F/TDF;   Drug: Placebo to match E/C/F/TAF
5 Recruiting Living Well Project for Persons With AIDS
Condition: Acquired Immunodeficiency Syndrome (AIDS)
Interventions: Behavioral: AIDS EPC Package plus MI;   Other: Standard of Care (SOC)
6 Recruiting Switching Undetectables to Selzentry
Conditions: Human Immunodeficiency Virus;   AIDS
Intervention: Drug: Maraviroc
7 Recruiting Music for Health Project
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: mobile phone application
8 Not yet recruiting Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
Conditions: Human Immunodeficiency Virus Infection;   Diabetes Mellitus
Intervention: Drug: extended-release exenatide
9 Active, not recruiting An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Continued Access Arm
10 Active, not recruiting Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
Condition: HIV Infection
Intervention: Drug: FTC/TDF (Truvada®)
11 Recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
12 Recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma
Conditions: HIV Infection;   HIV-associated Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Drug: dacarbazine;   Drug: brentuximab vedotin;   Other: pharmacological study;   Other: laboratory biomarker analysis
13 Completed A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects
Conditions: Chronic Hepatitis C;   Human Immunodeficiency Virus
Interventions: Drug: Sofosbuvir;   Drug: RBV
14 Recruiting Mater-Bronx Rapid HIV Testing Project.
Condition: Human Immunodeficiency Virus
Interventions: Other: No participant choice of counselor;   Other: Participant choice of counselor
15 Completed Feasibility of Using a Structured Daily Diary
Condition: HIV Infection
Intervention: Behavioral: Structured daily diary
16 Active, not recruiting Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: Placebo for DNA-HIV-PT123 vaccine;   Biological: Placebo for NYVAC-HIV-PT1 vaccine;   Biological: Placebo for NYVAC-HIV-PT4 vaccine
17 Recruiting Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at High Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir
18 Recruiting Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
Condition: HIV
Interventions: Behavioral: Suubi+Adherence;   Behavioral: Bolstered Standard of Care
19 Active, not recruiting Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests
Conditions: HIV;   Hepatitis B;   Hepatitis C;   Carcinoma, Hepatocellular;   AIDS
Interventions: Other: ELISA;   Other: Rapid Test
20 Enrolling by invitation TDF Long Term Study
Condition: HIV-infected Thai Children
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years